[1]张优高传玉.急性ST段抬高型心肌梗死质控现状与对策[J].中国卫生质量管理,2023,30(08):007-11.[doi:10.13912/j.cnki.chqm.2023.30.8.02 ]
　ZHANG You,GAO Chuanyu.Quality Control Status and Countermeasures of Acute ST-Segment Elevation Myocardial Infarction[J].Chinese Health Quality Management,2023,30(08):007-11.[doi:10.13912/j.cnki.chqm.2023.30.8.02 ]
点击复制

急性ST段抬高型心肌梗死质控现状与对策
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年08期
页码:
007-11
栏目:
特别关注
出版日期:
2023-08-15

文章信息/Info

Title:
Quality Control Status and Countermeasures of Acute ST-Segment Elevation Myocardial Infarction
作者:
张优高传玉
郑州大学华中阜外医院/阜外华中心血管病医院
Author(s):
ZHANG You; GAO Chuanyu
Central China Fuwai Hospital of Zhengzhou University
关键词:
急性ST段抬高型心肌梗死; 质控管理; 质控难点; 对策
Keywords:
Acute ST-Segment Elevation Myocardial Infarction;  Quality Control Management;  Difficulties of Quality Control;  Countermeasures
分类号:
R197.3；R54
DOI:
10.13912/j.cnki.chqm.2023.30.8.02
文献标志码:
A
摘要:
目的了解国内急性ST段抬高型心肌梗死（STEMI）救治现状，提出对策，为急性STEMI质控管理提供参考。方法收集国内公开发表的急性STEMI代表性研究数据，进行描述性分析。结果呼叫120入院比例较低，院前时间延迟突出，基层医院冠状动脉介入治疗比例较低，指南推荐药物血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂应用比例较低，住院死亡率和心力衰竭发生率较高。结论急性STEMI救治在院前时间延迟、再灌注治疗和药物应用方面与指南还存在较大差距。应进一步加大宣传力度，增强公众急救意识，优化基层医院再灌注治疗策略，提高基层医师对急性STEMI重症救治能力等。
Abstract:
ObjectiveTo investigate the treatment status of acute ST-segment elevation myocardial infarction (STEMI) in China, and put forward countermeasures to provide reference for STEMI quality control management.MethodsThe representative data of STEMI published in China were collected for descriptive analysis.ResultsThe hospital admission rate through calling 120 was low, the pre-hospital time was delayed prominently, the proportion of coronary interventional therapy was lower in grass-roots hospital, the proportion of angiotensin-converting enzyme inhibitor/angiotensin receptor antagonist was low, and the incidence of in-hospital mortality and heart failure was high.Conclusion There was still a big gap between the treatment of STEMI and the guidelines in the aspects of pre-hospital delay, reperfusion therapy and drug use. To improve STEMI management, publicity should further strengthen to enhance public awareness of first aid, optimize reperfusion treatment strategies in grass-roots hospital, and improve grass-roots hospital doctors' ability to treat severe STEMI.

参考文献/References:

［1］中国胸痛中心联盟，中国心血管健康联盟，苏州工业园区心血管健康研究院.中国胸痛中心常态化质控方案［J］. 中国急救复苏与灾害医学杂志, 2020, 15(6): 637-638. ［2］中国胸痛中心联盟.中国胸痛中心质控指标及考核办法［EB/OL］.(2021-06-11)［2023-04-15］.https://www.chinacpc.org/home/aview/911. ［3］窦克非, 王虹剑. 2019年中国成人急性ST段抬高型心肌梗死医疗质量控制报告［J］. 中国循环杂志, 2020, 35(4): 313-325. ［4］国家卫生健康委员会.心血管系统疾病相关专业医疗质量控制指标(2021年版)［J］. 中国循环杂志, 2021, 36(8): 733-742. ［5］国家心血管病医疗质量管理与控制中心冠心病专家工作组.成人急性ST段抬高型心肌梗死医疗质量评价指标体系的中国专家共识［J］. 中华心血管病杂志, 2018, 46(11): 849-856. ［6］XU H, YANG Y, WANG C, et al. Association of hospital-level differences in care with outcomes among patients with acute st-segment elevation myocardial infarction in China［J］. JAMA Network Open, 2020, 3(10): e2021677. ［7］LI J, LI X, WANG Q, et al. St-segment elevation myocardial infarction in china from 2001 to 2011 (the china peace-retrospective acute myocardial infarction study): a retrospective analysis of hospital data［J］. Lancet, 2015, 385(9966): 441-451. ［8］ZHONG Q, GAO Y, ZHENG X, et al. Geographic variation in process and outcomes of care for patients with acute myocardial infarction in china from 2001 to 2015［J］. JAMA Network Open, 2020, 3(10): e2021182. ［9］HAO Y, LIU J. Sex differences in in-hospital management and outcomes of patients with acute coronary syndrome［J］. Circulation, 2019, 139(15):1776-1785.［10］中国胸痛中心联盟. 《中国胸痛中心质控报告（2020）》概要［J］. 中国介入心脏病学杂志, 2021, 29(6): 313-317. ［11］中国胸痛中心联盟.《中国胸痛中心质控报告（2021）》概要［J］. 中国介入心脏病学杂志, 2022, 30(5): 321-327. ［12］ZHANG Y, WANG S, CHENG Q, et al. Reperfusion strategy and in-hospital outcomes for st elevation myocardial infarction in secondary and tertiary hospitals in predominantly rural central china: a multicentre, prospective and observational study［J］. BMJ Open, 2021, 11(12): e053510-e053510. ［13］张 优, 高传玉, 段广才,等.河南省不同级别医院急性ST段抬高型心肌梗死患者早期再灌注治疗现状调查［J］. 中华心血管病杂志, 2015, 43(10): 858-862. ［14］中国医师协会胸痛专业委员会中华心血管病杂志网络版编辑委员会急性心肌梗死后心室重构防治专家共识起草组.急性心肌梗死后心室重构防治专家共识［J］. 中华心血管病杂志（网络版）, 2020, 3(1): 1-7. ［15］中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)［J］. 中华心血管病杂志, 2019,47(10): 766-783. ［16］ZHANG H, MASOUDI FA, LI J, et al. National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study［J］. Am Heart J, 2015,170(3): 506-515. ［17］LIU J, MASOUDI FA, SPERTUS JA, et al. Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study［J］. J Am Heart Assoc, 2015, 4(2):e001343. ［18］国家卫生计生委合理用药专家委员会, 中国药师协会.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南(第2版)［J］. 中国医学前沿杂志（电子版）, 2019, 11(1): 40-65. ［19］何 奔, 韩雅玲.中国ST段抬高型心肌梗死救治现状及应有对策［J］. 中华心血管病杂志, 2019, 47(2): 82-84. ［20］HAN YL, LIU JN, JING QM, et al. The efficacy and safety of pharmacoinvasive therapy with prourokinase for acute st-segment elevation myocardial infarction patients with expected long percutaneous coronary intervention-related delay［J］. Cardiovasc Ther, 2013, 31(5): 285-290. ［21］肖朝文,简伟研.我国中部某地区急性ST段心肌梗死医疗质量研究［J］.中国卫生质量管理,2019,26(5):26-29. ［22］刘惠亮,张 蛟,霍 勇,等.中国胸痛中心建设现状和未来发展［J］.中国研究型医院,2020,7(1):78-82.

相似文献/References:

[1]张永芳吴永明王胜男王遥谭燕姜安琪刘国娥潘速跃.广东省脑死亡质控数据回顾分析及策略探讨[J].中国卫生质量管理,2022,29(03):015.[doi:10.13912/j.cnki.chqm.2022.29.3.05 ]
　ZHANG Yongfang,WU Yongming,WANG Shengnan.Retrospective Analysis and Strategy Discussion on Quality Control Data of Brain Death in Guangdong Province[J].Chinese Health Quality Management,2022,29(08):015.[doi:10.13912/j.cnki.chqm.2022.29.3.05 ]
[2]窦克非王虹剑韩雅玲杨跃进.全国急性ST段抬高型心肌梗死(STEMI)医疗服务与质量安全报告分析[J].中国卫生质量管理,2023,30(08):001.[doi:10.13912/j.cnki.chqm.2023.30.8.01 ]
　DOU Kefei,WANG Hongjian,HAN Yaling.Analysis of Medical Service and Quality Safety Report of Acute ST-Segment Elevation Myocardial Infarction (STEMI) in China[J].Chinese Health Quality Management,2023,30(08):001.[doi:10.13912/j.cnki.chqm.2023.30.8.01 ]
[3]孟浩宇孔祥清.提升区域内急性ST段抬高型心肌梗死再灌注治疗率的江苏经验[J].中国卫生质量管理,2023,30(08):012.[doi:10.13912/j.cnki.chqm.2023.30.8.03 ]
　MENG Haoyu,KONG Xiangqing.Jiangsu Experience to Improve the Reperfusion Treatment Rate of Acute ST-Segment Elevation Myocardial Infarction in the Region[J].Chinese Health Quality Management,2023,30(08):012.[doi:10.13912/j.cnki.chqm.2023.30.8.03 ]
[4]许静胡昊蒋晓蕾郑丽梅杨会志.提升急性ST段抬高型心肌梗死规范化诊疗水平的探索与实践[J].中国卫生质量管理,2023,30(08):016.[doi:10.13912/j.cnki.chqm.2023.30.8.04 ]
　XU Jing,HU Hao,JIANG Xiaolei.Exploration and Practice in Improving the Standardized Diagnosis and Treatment Level of Acute ST-Segment Elevation Myocardial Infarction[J].Chinese Health Quality Management,2023,30(08):016.[doi:10.13912/j.cnki.chqm.2023.30.8.04 ]

更新日期/Last Update: 2023-08-15